BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34575368)

  • 41. Epidemiology of Signet Ring Cell Adenocarcinomas.
    Benesch MGK; Mathieson A
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of Long-Time Survivors in Nonmetastatic Colorectal Signet Ring Cell Carcinoma: A Large Population-Based Study.
    Zhang W; Gong W; Wu C; Li M; Tu X
    Gastroenterol Res Pract; 2022; 2022():5393571. PubMed ID: 36032271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas.
    Merchant SH; Amin MB; Tamboli P; Ro J; Ordóñez NG; Ayala AG; Czerniak BA; Ro JY
    Am J Surg Pathol; 2001 Dec; 25(12):1515-9. PubMed ID: 11717541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Data on the characteristics and the survival of korean patients with colorectal cancer from the Korea central cancer registry.
    Park HC; Shin A; Kim BW; Jung KW; Won YJ; Oh JH; Jeong SY; Yu CS; Lee BH
    Ann Coloproctol; 2013 Aug; 29(4):144-9. PubMed ID: 24032114
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary lung carcinoma with signet-ring cell carcinoma components: clinicopathological analysis of 39 cases.
    Tsuta K; Ishii G; Yoh K; Nitadori J; Hasebe T; Nishiwaki Y; Endoh Y; Kodama T; Nagai K; Ochiai A
    Am J Surg Pathol; 2004 Jul; 28(7):868-74. PubMed ID: 15223955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge.
    Pernot S; Voron T; Perkins G; Lagorce-Pages C; Berger A; Taieb J
    World J Gastroenterol; 2015 Oct; 21(40):11428-38. PubMed ID: 26523107
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Predictive and Guidance Value of Signet Ring Cell Histology for Stage II/III Colon Cancer Response to Chemotherapy.
    Jiang H; Shao D; Zhao P; Wu Y
    Front Oncol; 2021; 11():631995. PubMed ID: 33708632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced glutamine utilization mediated by SLC1A5 and GPT2 is an essential metabolic feature of colorectal signet ring cell carcinoma with therapeutic potential.
    Wang R; Xiang W; Xu Y; Han L; Li Q; Dai W; Cai G
    Ann Transl Med; 2020 Mar; 8(6):302. PubMed ID: 32355746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and genomic characteristics of mucosal signet-ring cell carcinoma in Helicobacter pylori-uninfected stomach.
    Kiso M; Urabe Y; Ito M; Masuda K; Boda T; Kotachi T; Hata K; Yorita N; Nagasaki N; Abduwali M; Hiyama Y; Oka S; Tanaka S; Chayama K
    BMC Gastroenterol; 2020 Jul; 20(1):243. PubMed ID: 32727394
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Signet-ring cell carcinoma of colorectum--current perspectives and molecular biology.
    Gopalan V; Smith RA; Ho YH; Lam AK
    Int J Colorectal Dis; 2011 Feb; 26(2):127-33. PubMed ID: 20686774
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristics and Survival of Korean Patients With Colorectal Cancer Based on Data From the Korea Central Cancer Registry Data.
    Hur H; Oh CM; Won YJ; Oh JH; Kim NK
    Ann Coloproctol; 2018 Aug; 34(4):212-221. PubMed ID: 30208684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Malignant Transformation of Long-Standing Ileal Crohn's Disease Likely Favors Signet Ring Cell Adenocarcinoma Histology.
    Benesch MGK; Nelson ED; O'Brien SBL
    World J Oncol; 2023 Dec; 14(6):447-456. PubMed ID: 38022405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduced E-cadherin expression as a cause of distinctive signet-ring cell variant in colorectal carcinoma.
    Kim HC; Kim HJ; Kim JC
    J Korean Med Sci; 2002 Feb; 17(1):23-8. PubMed ID: 11850584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytologic diagnosis of signet-ring cell carcinoma of the breast.
    Kamiya M; Mizuguchi K; Yoshimoto M; Tanaka M; Motegi S; Matushima H; Ishizawa M; Nakamura K
    Acta Cytol; 1998; 42(3):650-6. PubMed ID: 9622682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of metastasis between early-onset and late-onset gastric signet ring cell carcinoma.
    Zhou QP; Ge YH; Liu CY
    BMC Gastroenterol; 2020 Nov; 20(1):380. PubMed ID: 33189128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Poorer prognosis for neuroendocrine carcinoma than signet ring cell cancer of the colon and rectum (CRC-NEC): a propensity score matching analysis of patients from the Surveillance, Epidemiology, and End Results (SEER) database.
    Chen Y; Tu J; Zhou S; Fu J; Wang Q
    Int J Colorectal Dis; 2021 Apr; 36(4):745-756. PubMed ID: 33415449
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Impact of Epidemiological Factors and Treatment Interventions on Survival in Patients With Signet Ring Cell Carcinoma of the Pancreas.
    Patel M; Hans HS; Pan K; Khan H; Donath E; Caldera H
    Am J Clin Oncol; 2018 Dec; 41(12):1176-1184. PubMed ID: 29672365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Rare Case of Signet Cell Carcinoma of Transverse Colon in a Young Patient With Ulcerative Colitis.
    Mohamed M; Al Hillan A; Zurkovsky E; Zheng M; Asif A; Akhtar R; Hossain M; Pyrsopoulos NT
    J Med Cases; 2020 May; 11(5):135-139. PubMed ID: 34434383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary signet ring cell carcinoma of the colon and rectum.
    Arifi S; Elmesbahi O; Amarti Riffi A
    Bull Cancer; 2015 Oct; 102(10):880-8. PubMed ID: 26412710
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of survival outcomes and survival prediction in patients with primary colorectal MANEC and primary colorectal SRCC: a population-based propensity-score matching study.
    Zhu Y; Thandar M; Cheng J; Zhang X; Zhao Z; Huang S; Chi P
    J Cancer Res Clin Oncol; 2023 Nov; 149(14):13279-13300. PubMed ID: 37481754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.